Associate Director

John A. Castoro, PhD,

Bristol-Myers Squibb

Impact from the Recent Issuance of ANVISA Resolution RDC-53/2015 on Pharmaceutical Small Molecule Forced Degradation ...
Thursday, March 31, 2016
Forced degradation studies (FDS) are essential in the development of stability indicating methods to gain understanding of the intrinsic stability characteristics of a Drug Substance (DS). Performance of stress studies ... read more
Utilizing a Novel Disperser Technology to Accelerate Sample Extraction of Pharmaceutical Solid Dosage Forms
Wednesday, May 20, 2015
Development and subsequent application of robust analytical methods are critical in the generation of accurate and precise analytical data to ensure the quality and safety of pharmaceutical solid dosage form products. Sample... read more